The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Exploring the efficacy of belzutifan in the treatment of renal cell carcinoma associated with von Hippel-Lindau disease: A comparative analysis with external control arm.
 
W Linehan
No Relationships to Disclose
 
Thomas Jemielita
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Jerry Cornell
Employment - Merck Sharp & Dohme
 
Ke Chen
No Relationships to Disclose
 
Mark Ball
No Relationships to Disclose
 
Ramaprasad Srinivasan
Research Funding - Allogene Therapeutics (Inst); Allogene Therapeutics (Inst); NiKang Therapeutics (Inst); Peloton Therapeutics (Inst)
 
Yanfang Liu
Employment - Merck Sharp & Dohme, LLC
Stock and Other Ownership Interests - Merck Sharp & Dohme, LLC
 
Rodolfo Perini
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Cathy Anne Pinto
Employment - Merck Sharp & Dohme LLC, a subsidary of Merck & Co., Inc, Rahway, NJ USA
Stock and Other Ownership Interests - Merck; Merck Sharp & Dohme LLC, a subsidary of Merck & Co., Inc, Rahway, NJ USA
Research Funding - Merck (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme LLC, a subsidary of Merck & Co., Inc, Rahway, NJ USA